See more : TFI International Inc. (TFII) Income Statement Analysis – Financial Results
Complete financial analysis of CareMax, Inc. (CMAX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of CareMax, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- XRF Scientific Limited (XRF.AX) Income Statement Analysis – Financial Results
- Ashoka Refineries Limited (ASHOKRE.BO) Income Statement Analysis – Financial Results
- Sterling Check Corp. (STER) Income Statement Analysis – Financial Results
- American Potash Corp. (KCL.CN) Income Statement Analysis – Financial Results
- ClearView Wealth Limited (CVW.AX) Income Statement Analysis – Financial Results
CareMax, Inc. (CMAX)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.caremax.com
About CareMax, Inc.
CareMax, Inc. provides medical services through physicians and health care professionals. It offers a suite of health care and social services to its patients, including primary care, specialty care, telemedicine, health and wellness, optometry, dental, pharmacy, and transportation. The company also provides CareOptimize, a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians in the United States. As of December 31, 2021, it operated 48 multi-specialty medical care centers in Florida, Tennessee, and New York. The company is headquartered in Miami, Florida.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 751.10M | 631.13M | 295.76M | 103.42M | 90.60M | 72.38M |
| Cost of Revenue | 737.20M | 550.83M | 264.31M | 83.42M | 51.62M | 44.16M |
| Gross Profit | 13.90M | 80.30M | 31.45M | 20.00M | 38.98M | 28.22M |
| Gross Profit Ratio | 1.85% | 12.72% | 10.63% | 19.34% | 43.02% | 38.99% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 80.68M | 75.82M | 40.58M | 7.75M | 11.56M | 23.53M |
| Selling & Marketing | 14.27M | 11.76M | 4.96M | 1.07M | 20.85M | 1.21M |
| SG&A | 94.96M | 87.59M | 45.53M | 8.82M | 32.41M | 24.74M |
| Other Expenses | 575.10M | 21.72M | 13.22M | 1.50M | 0.00 | 0.00 |
| Operating Expenses | 670.05M | 109.30M | 58.75M | 10.32M | 32.41M | 24.74M |
| Cost & Expenses | 1.41B | 660.13M | 323.06M | 93.74M | 84.04M | 68.90M |
| Interest Income | 0.00 | 20.24M | 4.49M | 1.66M | 720.40K | 0.00 |
| Interest Expense | 54.43M | 20.24M | 4.49M | 1.66M | 0.00 | 0.00 |
| Depreciation & Amortization | 39.31M | 21.72M | 13.22M | 1.50M | 975.90K | 602.85K |
| EBITDA | -590.46M | -15.38M | 11.19M | 11.18M | 7.54M | 4.09M |
| EBITDA Ratio | -78.61% | -1.07% | -11.80% | 10.81% | 8.32% | 5.65% |
| Operating Income | -656.15M | -29.00M | -27.30M | 9.68M | 6.57M | 3.49M |
| Operating Income Ratio | -87.36% | -4.60% | -9.23% | 9.36% | 7.25% | 4.82% |
| Total Other Income/Expenses | -28.06M | -28.34M | 22.31M | -2.11M | -720.40K | 0.00 |
| Income Before Tax | -684.21M | -57.34M | -6.52M | 7.57M | 5.85M | 3.49M |
| Income Before Tax Ratio | -91.09% | -9.09% | -2.20% | 7.32% | 6.45% | 4.82% |
| Income Tax Expense | -863.00K | -19.54M | 159.00K | 1.63M | -173.19K | 16.47K |
| Net Income | -683.35M | -37.80M | -6.68M | 5.94M | 6.02M | 3.47M |
| Net Income Ratio | -90.98% | -5.99% | -2.26% | 5.75% | 6.64% | 4.79% |
| EPS | -183.30 | -12.49 | -3.90 | 16.42 | 0.00 | 9.54 |
| EPS Diluted | -183.30 | -12.49 | -3.81 | 16.51 | 0.00 | 9.64 |
| Weighted Avg Shares Out | 3.73M | 3.03M | 1.71M | 361.95K | 0.00 | 363.66K |
| Weighted Avg Shares Out (Dil) | 3.73M | 3.03M | 1.75M | 359.87K | 0.00 | 359.87K |
New Strong Sell Stocks for February 1st
New Strong Sell Stocks for January 30th
CareMax: Penetrating The Large U.S. Healthcare Industry
CareMax, Inc. to Present at the 41st Annual J.P. Morgan Healthcare Conference
CareMax, Inc. to Present at the 41st Annual J.P. Morgan Healthcare Conference
CareMax: Market Reception To Latest Developments Poor, Revise To Hold
CareMax, Inc. (CMAX) Q3 2022 Earnings Call Transcript
CareMax, Inc. Completes Acquisition of Medicare Value-Based Care Business of Steward Health Care System
CareMax, Inc. Completes Acquisition of Medicare Value-Based Care Business of Steward Health Care System
CareMax, Inc. (CMAX) Reports Q3 Loss, Tops Revenue Estimates
Source: https://incomestatements.info
Category: Stock Reports